Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOBEX donor exosome immunotherapy for prevention of liver transplant rejection
NL-OMON41041Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 2014
- Countries
- 1
01
Overview
Open-label, single-arm trial in graft rejection and Hepatic transplant rejection (LTR), sponsored by Erasmus MC. Primary endpoints: Induction of apoptosis in donor-specific T cells responding directly to alloantigen and Induction of anergy in donor-specific T cells responding to indirectly presented alloantigens. Planned start Jun 2014; status: not yet recruiting.
02
Conditions
graft rejectionHepatic transplant rejection (LTR)
Beyond the preview
Go deeper on NL-OMON41041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41041.